2014 promises to be a year of positive new initiatives for EURADIA and the diabetes research community more generally. As a result of sustained efforts by many in the research and advocacy world, diabetes is now gaining more attention, this being particularly evident at the recent kick-off meeting for the EU’s new Joint Action on Chronic Diseases in Madrid (CHRODIS-JA). We marked the welcome announcement of Horizon 2020 funding calls with our own, new quarterly funding bulletin which we hope will be of use. Do take a look here. At a time when EU diabetes research funding is paramount, we will also continue to send out regular email funding alerts.
Closer to home, we are pleased to announce that the ‘InterConnect’ project is now moving ahead apace. With the support of the European Commission, this 4-year scoping project aims to establish a global network that will facilitate the co-ordination of population research on the interaction between genetic and environmental factors in the causes of obesity and diabetes. EURADIA is specifically responsible for developing a sustainable and dynamic network of stakeholders and we will also be disseminating information about InterConnect to the research community, funders, stakeholders and the wider public. Please do visit InterConnect’s new website – your feedback is always most welcome.
We are also in the process updating the EURADIA Diamap Project and the Diamap Road Map Report, due to begin work this Spring. DIAMAP was originally a European Commission FP-7 funded project which undertook a wide survey of the European diabetes research landscape, from which expert opinion could identify gaps and highlight strengths in order to guide a Road Map strategy for diabetes research in Europe. Read more in our February newsletter here.
EURADIA Priorities for 2013-2017
1. DIAMAP 2020: Road Map for Diabetes Research in Europe: update and extend the DIAMAP Road Map. Undertake a benchmarking exercise to review the current status of diabetes research and funding in Europe by updating and extending the DIAMAP databases and expert road maps. Continue to use DIAMAP as a model for other disease areas. The European Platform for Clinical Research in Diabetes (EPCRD) will be developed as a tool for improving diabetes clinical research across Europe.
2. High level advocacy (Horizon 2020): build on past advocacy success at European level and set clear goals (and define messaging) up until 2017:
3. Stakeholder engagement: develop a long-term strategy to harness support from the wider community including people with diabetes.
4. Networking projects: build the capacity of EURADIA to provide service to the diabetes research community by development of proposals (for example to the EU) for specific programmes to assist translation of basic research into clinical practice.
5. Communications: promote and raise awareness of the importance of diabetes research and the place of EURADIA to wider European audience.
Mailing address: Milnwood, 13 North Parade, Horsham, West Sussex, RH12 2BT, UK
Tel/Fax: 0044 (0)1403 276363